Man Group PLC Tg Therapeutics, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $10.7 Million - $24.1 Million	689,236 New	689,236 $17.1 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $71,878 - $169,725	-14,347 Reduced 44.08%	18,200 $215,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $389,140 - $715,268	-85,151 Reduced 72.35%	32,547 $193,000
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $440,190 - $1.25 Million	117,698 New	117,698 $500,000
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $1.02 Million - $2.39 Million	-67,196 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $477,570 - $886,947	-21,927 Reduced 24.6%	67,196 $2.24 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $433,290 - $652,734	-13,332 Reduced 13.01%	89,123 $3.46 Million
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $4.29 Million - $5.59 Million	-102,993 Reduced 50.13%	102,455 $4.94 Million
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $117,151 - $254,516	-4,636 Reduced 2.21%	205,448 $10.7 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $4.83 Million - $7.11 Million	-261,005 Reduced 55.4%	210,084 $5.62 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $4.19 Million - $10.3 Million	471,089 New	471,089 $9.18 Million
Q4 2019 Feb 18, 2020	SELL	$5.1 - $11.2 $324,018 - $711,569	-63,533 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $461,082 - $770,469	-85,703 Reduced 57.43%	63,533 $357,000
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $253,934 - $350,325	-40,500 Reduced 21.35%	149,236 $1.29 Million
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $762,738 - $1.53 Million	189,736 New	189,736 $1.53 Million
Q3 2018 Nov 14, 2018	SELL	$5.15 - $14.0 $413,287 - $1.12 Million	-80,250 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$12.5 - $15.0 $1 Million - $1.2 Million	80,250 New	80,250 $1.06 Million

Others Institutions Holding TGTX

# of Institutions

336

Shares Held

87.6M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$448 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$332 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$265 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$104 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$93.4 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account